Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Psychiatry/Psychology
Schizophrenia and Schizoaffective Disorders
Have you been diagnosed with Schizophrenia?
Cerritos, CA - Schizophrenia
A 6-week Inpatient trial for patients with Acute Exacerbation of Schizophrenia
Inpatient Schizophrenia Trial
Outpatient Schizophrenia Trial
Do you have schizophrenia or schizoaffective disorder?
An inpatient study comparing different types of the same study medication administered to subjects with schisophrenia, schizoaffective disorder, or schisophreniform disorder.
Schizophrenia and Schizoaffective Disorders Study
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Genetics of Schizophrenia
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
The study is looking at the metabolic side effects of the new antipsychotic medications. Participants should be stable on one of the following medications: olanzapine (zyprexa), ziprasidone (geodon), risperidone (risperdal) or aripiprazole (abilify). Patient's medications won't be changed. The study involves 3 visits at the Palo Alto VA and Stanford Hospital.
Inpatient Schizophrenia Trial
Outpatient Schizophrenia Trial
Outpatient Schizophrenia
First Episode Psychosis Study (CAFÉ)
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Treatment of Schizoaffective Disorder Using Mifepristone
Atlanta, GA - Schizophrenia
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Assess long term safety, tolerability and effectiveness of lurasidone over a 12 month double blind period followed by a 6 month open label extension phase
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
Study to evaluate the efficacy tolerability, and safety of an intramuscular depot formulation of apripirazole as maintenance therapy in patients with schizophrenia
To evaluate the efficacy and safety of Armodanifil as adjunctive therapy in adults with schizophrenia
To evaluate the safety, efficiacy, and tolerability of cariprazine relative to placebo in patients with acute exacerbation of schizophrenia
CAMP Schizophrenia Study
Schizophrenia Research Study
Genetic and Epigenetic Studies of Schizophrenia: Healthy Subject Sample Collection
Intranasal Insulin Treatment in Patients with Schizophrenia
Intranasal Insulin Treatment in Patients with Schizophrenia
Spatiotemporal dynamics of contextual processing in schizophrenia, autism spectrum disorder, and obsessive-compulsive disorder
TELEMISARTAN AS AN ADJUNCTIVE TREATMENT FOR METABOLIC PROBLEMS IN PATIENTS WITH SCHIZOPHRENIA
The Partners Genetics Study of Schizophrenia
A long term safety, tolerability, and effectiveness of XXXX in subjects with Schizophrenia or Schizoaffective disorder: A randomized, active comparator-controlled study.
A phase 2a, multi-center randomized, double-blind parallel group, placebo-controlled study to evaluate the safety and efficacy of XXX as adjunctive treatment in combination with a preexisting antipsychotic in patients with cognitive impairments associated with schizophrenia.
A Phase IIa, Single-Blind, Placebo Controlled Trial to Evaluate the Pro-Cognitive Effects of XXXX in Patients with Schizophrenia.
A randomized, double-blind, parallel-group, flexible-dose study exploring the neurocognitive effects of XXXX vs. XXXX in patients with schizophrenia using the MATRICS Consensus Cognitive Battery.
A Single Dose, Open-Label, Randomized, 2-Period, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of XXXX 3-month formulation in Subjects with Schizophrenia.
A Single-arm Evaluation of the Safety of XXXX Extended-Release (ER) in Subjects with Schizophrenia or Schizoaffective Disorder with Hepatic Disease.
A Single-arm Evaluation of the Safety of XXXX Extended-Release (ER) in Subjects with Schizophrenia or Schizoaffective Disorder with Hepatic Disease.
An open label study to evaluate the effect of repeated administration of XXXX on the pharmacokinetics of XXXX following administration of the immediate release formulation of Tablets XXXX in patients with Schizophrenia.
An Open-Label, Long-Term, Multiple-Dose, Safety and Tolerability, Pharmacokinetic Study of XXXX in the Treatment of Subjects with Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Are you suffering from Schizophrenia?
What is Schizophrenia?
Schizophrenia is a chronic and disabling illness that affects 2 million American every year. It can cause disorganized thinking, hallucinations (seeing things or hearing voices), and social withdrawal from friends/family as well as feelings of anxiety and depression.
Holliswood, NY - Schizophrenia
Are you suffering from Schizophrenia?
Are you suffering from Schizophrenia?
Clinical Antipsychotic Trials of Intervention Effectiveness (C.A.T.I.E)
Comparison of Atypicals for First Episode (C.A.F.E)
Molecular Genetics of Schizophrenia
White Matter Abnormalities in Schizophrenia
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Clinical research trials currently enrolling to treat those with Schizophrenia.
Schizophrenia Research Study- Volunteers Needed
Washington, DC - Schizophrenia
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
